Fidelity Advisor Biotechnology Fund ARGX Holdings History
Fidelity Advisor Biotechnology Fund's argenx SE Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 98,000.00 shares of argenx SE(ARGX), totaling $63.22 Mil. This investment constitutes 4.65% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.16% of the outstanding argenx SE(ARGX) stock.
The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 5 purchases of ARGX, at an average price of $166.09, for a total of 403,700.00 shares. In addition, there have been 9 sales at an average price of $406.94 for 305,700.00 shares. Based on historical transaction data and ARGX's current price of $564.71, Fidelity Advisor Biotechnology Fund's estimated gain on his ARGX holdings is $112.69 Mil, reflecting a 168.08% gain to date.
Fidelity Advisor Biotechnology Fund ARGX ($564.71) Holding Chart
Fidelity Advisor Biotechnology Fund ARGX ($564.71) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1